-

Claritas Rx In-Depth Head-to-Head Comparison of KPIs Allows Market Access Teams to Make Smarter, Data-Driven Decisions

Understanding Competitor Fill Rates, Time-to-Fill, and Physician Experience Strengthens Strategies, Improves Patient Access and Fuels Brand Growth

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, announced the availability of AI-powered Performance Benchmarking. The service turns comprehensive specialty data into a real-time view of how brands compare against their competitors. Market Alerts enable brands to respond faster to competitor shifts—such as identifying when patients discontinue a competitor’s therapy—allowing for timely engagement with prescribers. Performance Benchmarking offers the first and only real-world data set that quantifies key market access metrics often invisible in claims, including fill rates, time to fill, discontinuation dates and reasons, and more, across specialty brands.

With in-depth head-to-head comparison of key performance indicators (KPIs)—including fill rates, time-to-fill and physician experience—teams can make smarter, data-driven decisions that strengthen strategies, improve patient access and fuel brand growth.

Claritas Rx Performance Benchmarking allows Market Access executives to:

  • Compare brand performance by measuring specific brand KPIs—such as fill rates, abandonment, and time-to-fill—against a custom market basket, therapeutic area, or the entire industry.
  • Tailor benchmarking to specific regions, treatment classes, or competitive sets for highly relevant performance evaluation.
  • Leverage real-world patient Rx abandonment reason data to measure the effectiveness of payer contracts and optimize your gross-to-net strategy.
  • Utilize unique Claritas Rx market basket metadata to benchmark what good looks like for patient services, including hub operations, prior authorization (PA) cycle time, free goods use and more.
  • Tokenize and integrate with other data to help identify new commercial opportunities and engage prescribers.
  • Augment advanced predictive analytics with rich historical and real-time Rx trends, such as fill rates, patient abandonment/discontinuation dates and reasons, and much more.

“Performance Benchmarking helps clarify your specialty market position by synthesizing your own internal data with insights from analogs and competitors across disease area, treatment method, and market dynamics,” said Michael Fitzgibbons, CEO of Claritas Rx. “Powered by Claritas Rx’s unique pre-dispense patient journey data, this approach sets benchmarks, informs pricing, and enables KPI comparisons for smarter decisions and stronger brand performance.”

Performance Benchmarking Two Ways

There are two ways to implement Claritas Rx Performance Benchmarking: as an ongoing subscription model with a customized interactive dashboard or a bespoke consulting project.

  1. Subscription: An interactive dashboard allows clients to directly access and analyze real-time benchmarking data on fill rates, time-to-fill, and abandonment versus competitors.
  2. Consulting Project: The consulting approach provides tailored analysis and a report, with expert recommendations, and answers to specific strategic questions.

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete view of the patient journey with purpose-built technologies, we predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.

Contacts

Media Contact: Emily Brennan, EBrennan@ClaritasRx.com

Claritas Rx


Release Versions

Contacts

Media Contact: Emily Brennan, EBrennan@ClaritasRx.com

More News From Claritas Rx

Everest Group Finds Patients in Rare and Specialty Markets Are Getting More Touches and Less Help

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the release of a new Everest Group white paper: From Fragmented to Orchestrated: Omnichannel Engagement in Patient Services. The white paper addresses a persistent challenge in life sciences: despite significant investment in omnichannel patient engagement, most patient support programs still deliver fragmented, inconsistent experiences. Patients receive repeated outreach, conflicting guidance...

Claritas Rx Wins Fierce AI Innovation Award for Omnichannel Engagement Strategy

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced it has won the Fierce AI Innovation Award in the Omnichannel Engagement Strategy category. The award recognizes Patient Watchtower™ and the Patient Services Omnichannel CRM — two connected AI-powered solutions that let biopharma manufacturers spot risk earlier in the patient journey and coordinate real-time action across every partner helping patients start and stay on therapy. For patients p...

Claritas Rx Named to the 2026 Inc. 5000 List for the Second Consecutive Year

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, announced today it has been named to the 2026 Inc. 5000 list for the second consecutive year, earning a place among America's fastest-growing private companies. The list is the most prestigious ranking of the nation’s most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the eco...
Back to Newsroom